Stock Track | SBP GROUP Soars 5.63% Intraday on Buyback Plan, Pipeline Milestones, and Sector Rally

Stock Track
Jun 29

SBP GROUP's stock price surged 5.63% during intraday trading on Monday, reflecting strong investor confidence.

The significant movement is supported by the company's recently announced share buyback plan of up to HK$2 billion over the next 12 months, with the board explicitly stating it believes the company is severely undervalued. This follows a recent repurchase of 11.553 million shares for approximately HK$49.1 million.

Further catalysts include key pipeline advancements, such as the NMPA acceptance of the new drug application for tecotabart vedotin (LM-302) for gastric cancer and marketing approval for Peceleganan Spray for wound infections. The positive sentiment was also buoyed by a broad rally across the pharmaceuticals sector during the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10